The target of this guideline is all Canadian healthcare professionals including primary care providers, medical specialists, and members of multidisciplinary teams who treat patients with fibromyalgia (FM). 

To a lesser degree, it is also relevant to patients with FM, who may also benefit from an understanding of this condition.